Online inquiry

IVTScrip™ mRNA-Human ASAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28691MR)

This product GTTS-WK28691MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASAP1 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001247996.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 50807
UniProt ID Q9ULH1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28691MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK12711MR IVTScrip™ mRNA-Human ACAP1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ACAP1
GTTS-WK25710MR IVTScrip™ mRNA-Human ASGR1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ASGR1
GTTS-WK26803MR IVTScrip™ mRNA-Human ARHGAP9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP9
GTTS-WK9678MR IVTScrip™ mRNA-Human ABLIM1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ABLIM1
GTTS-WK12505MR IVTScrip™ mRNA-Human ADAMTS6, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADAMTS6
GTTS-WK25807MR IVTScrip™ mRNA-Human APH1A, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA APH1A
GTTS-WK19337MR IVTScrip™ mRNA-Human alpha-SMA, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA alpha-SMA
GTTS-WK7974MR IVTScrip™ mRNA-Human ACTR3C, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ACTR3C
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW